This grant funds state, territory, and city health departments to enhance viral hepatitis surveillance, outbreak response, testing, treatment, prevention, and elimination planning in high-impact settings.
Funder: Centers for Disease Control - NCHHSTP
Due Dates (Anticipated): December 2026
Funding Amounts: Estimated total program funding: $450,000,000; ~60 awards expected; award size not specified.
Summary: Supports integrated viral hepatitis surveillance, testing, treatment, and prevention efforts in states, territories, and large cities in the U.S.
This program supports state, territorial, and large city health departments in implementing integrated viral hepatitis surveillance and prevention activities. The initiative aims to strengthen outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Key strategies include developing and utilizing disease registries, conducting data matching, generating data summaries, monitoring program progress, enhancing case investigations, and building health department infrastructure to expand surveillance capacity.
Prevention efforts focus on elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and C testing and treatment, integrating services, and developing perinatal hepatitis C programs. The program is multi-component, with two required and two optional components:
Expected outcomes include improved surveillance and reporting, better strategic planning and collaboration, and expanded access to prevention, diagnosis, and treatment of viral hepatitis.